JPWO2023154307A5 - - Google Patents
Info
- Publication number
- JPWO2023154307A5 JPWO2023154307A5 JP2024546369A JP2024546369A JPWO2023154307A5 JP WO2023154307 A5 JPWO2023154307 A5 JP WO2023154307A5 JP 2024546369 A JP2024546369 A JP 2024546369A JP 2024546369 A JP2024546369 A JP 2024546369A JP WO2023154307 A5 JPWO2023154307 A5 JP WO2023154307A5
- Authority
- JP
- Japan
- Prior art keywords
- peg
- alkyldiyl
- succinimidyl
- alkyl
- heterocyclyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263308275P | 2022-02-09 | 2022-02-09 | |
| US63/308,275 | 2022-02-09 | ||
| PCT/US2023/012576 WO2023154307A1 (en) | 2022-02-09 | 2023-02-08 | Antibody-conjugated 8-sulfonyl-benzazepine compounds and their uses |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025505638A JP2025505638A (ja) | 2025-02-28 |
| JP2025505638A5 JP2025505638A5 (https=) | 2026-02-12 |
| JPWO2023154307A5 true JPWO2023154307A5 (https=) | 2026-02-12 |
Family
ID=85778754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024546369A Pending JP2025505638A (ja) | 2022-02-09 | 2023-02-08 | 抗体コンジュゲート８－スルホニル－ベンザゼピン化合物及びそれらの使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250127914A1 (https=) |
| EP (1) | EP4475893A1 (https=) |
| JP (1) | JP2025505638A (https=) |
| KR (1) | KR20240139086A (https=) |
| CN (1) | CN118843481A (https=) |
| AU (1) | AU2023216956A1 (https=) |
| IL (1) | IL314755A (https=) |
| MX (1) | MX2024009756A (https=) |
| TW (1) | TW202339806A (https=) |
| WO (1) | WO2023154307A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026050213A1 (en) * | 2024-08-27 | 2026-03-05 | Usbolt Biotherapeutics, Inc. | Tlr agonist immunoconjugates and uses thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3233835B1 (en) * | 2014-12-18 | 2019-01-23 | F.Hoffmann-La Roche Ag | Benzazepine sulfonamide compounds |
| CN108055842B (zh) * | 2015-09-17 | 2021-06-29 | 豪夫迈·罗氏有限公司 | 亚磺酰基苯基或磺亚胺酰基苯基苯并氮杂䓬 |
| EP3464274B1 (en) * | 2016-05-23 | 2020-05-27 | H. Hoffnabb-La Roche Ag | Benzazepine dicarboxamide compounds with secondary amide function |
| AU2019337654A1 (en) * | 2018-09-12 | 2021-04-08 | Silverback Therapeutics, Inc. | Substituted benzazepine compounds, conjugates, and uses thereof |
| AU2020291014B2 (en) * | 2019-06-13 | 2025-06-05 | Bolt Biotherapeutics, Inc. | Aminobenzazepine compounds, immunoconjugates, and uses thereof |
| JP2022549510A (ja) * | 2019-09-30 | 2022-11-25 | ボルト バイオセラピューティクス、インコーポレーテッド | アミド結合したアミノベンズアゼピン免疫複合体、及びその使用 |
| JP7735291B2 (ja) * | 2020-02-21 | 2025-09-08 | エーアールエス ファーマシューティカルズ、インコーポレイテッド | ネクチン－４抗体コンジュゲートおよびその使用 |
| CN115996756A (zh) * | 2020-05-08 | 2023-04-21 | 博尔特生物治疗药物有限公司 | 弹性蛋白酶底物肽连接子免疫缀合物及其用途 |
-
2023
- 2023-02-07 TW TW112104257A patent/TW202339806A/zh unknown
- 2023-02-08 KR KR1020247029749A patent/KR20240139086A/ko active Pending
- 2023-02-08 JP JP2024546369A patent/JP2025505638A/ja active Pending
- 2023-02-08 AU AU2023216956A patent/AU2023216956A1/en active Pending
- 2023-02-08 EP EP23713985.2A patent/EP4475893A1/en active Pending
- 2023-02-08 WO PCT/US2023/012576 patent/WO2023154307A1/en not_active Ceased
- 2023-02-08 US US18/835,130 patent/US20250127914A1/en active Pending
- 2023-02-08 MX MX2024009756A patent/MX2024009756A/es unknown
- 2023-02-08 CN CN202380026146.0A patent/CN118843481A/zh active Pending
- 2023-02-08 IL IL314755A patent/IL314755A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2462085C (en) | Cytotoxic agents | |
| WO2023131219A1 (en) | Conjugates, compositions and methods of use | |
| IL312845B2 (en) | Extacan derivatives, charge-linkers, and their conjugates | |
| KR960000234A (ko) | 메틸트리티오 항암제의 부형제-약물 컨쥬게이트, 이를 함유하는 제약학적 조성물 및 이의 제조 방법 | |
| ES2755101T3 (es) | Nuevos compuestos y conjugados de criptoficina, su preparación y su uso terapéutico | |
| JPWO2020252294A5 (https=) | ||
| JP6957629B2 (ja) | 非線状自壊性リンカーおよびそのコンジュゲート | |
| JPWO2021226440A5 (https=) | ||
| JP2020534300A5 (https=) | ||
| JPWO2021067242A5 (https=) | ||
| CN120826407A (zh) | 包含曲贝替定和芦比替定衍生物的抗体药物偶联物 | |
| JPWO2021081407A5 (https=) | ||
| JPWO2022272039A5 (https=) | ||
| JPWO2023154307A5 (https=) | ||
| JPWO2020084115A5 (https=) | ||
| JPWO2021225892A5 (https=) | ||
| JPWO2022125904A5 (https=) | ||
| JPWO2023154302A5 (https=) | ||
| JPWO2022125915A5 (https=) | ||
| JPWO2022125884A5 (ja) | 抗ｃｅａ免疫複合体、及びその使用 | |
| JPWO2021046112A5 (https=) | ||
| JPWO2023041006A5 (https=) | ||
| JPWO2022204536A5 (https=) | ||
| JPWO2022125891A5 (https=) | ||
| JPWO2022036101A5 (https=) |